Answer
Curosurf (poractant alfa) is indicated for prophylactic use in premature infants requiring intubation for stabilisation who are at risk of respiratory distress syndrome (RDS) or have evidence of surfactant deficiency.
Sources for this answer
- CurosurfChiesi Limited · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked